AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU

RecruitingNAAges 18 Years - anyAllMcGill University Health Centre/Research Institutโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Admitted to the Intensive Care Unit (ICU) * Started on antibiotics for any suspected or confirmed infection in the preceding 72 hours (about 3 days) * Treating doctor(s) willing to consider BV test result in antibiotic treatment decision making Exclusion Criteria: * Severe immunocompromise/immunosuppression 1. Congenital immunodeficiency 2. HIV with CD4 \< 20 3. Active chemotherapy and profound neutropenia (ANC \< 100) expected to last \> 7 days; 4. solid organ or stem cell transplant within preceding 6 months AND active GVHD 5. Receiving high dose steroids (Pred \> 20mg/day for \> or = 2 weeks) * Advanced metastatic cancer irrespective of treatment * Palliative intent, death imminent and inevitable within 4 weeks * Antibiotic to be discontinued within 24h (ex. Prophylaxis) * Active infection diagnosed and treated with antibiotics within preceding 2 weeks * Previously included during the same hospitalization
๐Ÿ’Š

What it tests

  • Biomarker-signature supported antibiotic treatment recommendation
  • Clinical assessment for antibiotic treatment decision
๐Ÿ“

Where

4 sites
Montreal General Hospital
Montreal, Canada
Research Institute of McGill University Health Center (RI-MUHC)
Montreal, Canada
Royal Victoria Hospital
Montreal, Canada
Research Institute McGill University Health Centre
Montreal, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy